News

heart data AI algorithm cardiologist doctor

San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

President Trump

State-level regulation of AI: President Trump has turned his thinking into action.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains changes in payment policy are making ambulatory surgical centers (ASC) and office based labs (OBL) more attractive to both cardiologists and larger health systems.

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.

These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

voice audio recording smartphone

According to attorneys representing a potential class action of plaintiffs, Sharp HealthCare was not forthcoming about its use of a tool for automatic note-taking. The technology allegedly captures everything said in an exam room, including sensitive details on diagnoses, and sends it to an offsite server.

Thumbnail

President Donald Trump wants to establish an AI Litigation Task Force to challenge any AI laws that may “harm innovation.” 

stock market nasdaq bulls and bears

“Going public is not a finish line. It’s the beginning of our next chapter,” CEO Caitlin Zulla, MPH, said in prepared remarks Dec. 11. 

Copper-based radiotracer excels at PSMA imaging

The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics. 

The Barostim device from CVRx continues to gain momentum as a go-to heart failure treatment. A free webinar is scheduled to examine the device's new CPT codes, which go into effect in 2026.

For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.

Vesalio enVast coronary mechanical thrombectomy system gained FDA in December 2025.

The newly cleared system offers clinicians a new option for capturing and removing large coronary thrombi in patients undergoing primary PCI.

Around the web

San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

State-level regulation of AI: President Trump has turned his thinking into action.

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.